John Read (psychologist)

Last updated

John Read is a psychologist and mental health researcher from England. He is professor of clinical psychology in the University of East London's School of Psychology.

Contents

Read was formerly a clinical psychologist in the Department of Psychology at the University of Auckland. His research interests include: attitudes towards 'mental illness', psycho-social causes of psychosis, and the role of the pharmaceutical industry in psychology. [1]

Before joining the university in 1994, Read worked for twenty years as a manager of mental health services, working with people experiencing psychosis. He is the Editor of the journal Psychosis and is on the editorial boards of two other journals. He is also on the executive board of the International Society for the Psychological Treatments of Schizophrenia. Read is the editor of Models of Madness: Psychological, Social and Biological Approaches to Schizophrenia (Routledge, 2004) which has sold over 10,000 copies and been translated into Chinese, Russian, Spanish and Swedish. In 2010 he received the New Zealand Psychological Society's Sir Thomas Hunter Award for 'excellence in scholarship, research and professional achievement'. [1] [2]

In 2010, Read and Richard Bentall co-authored a literature review on "The effectiveness of electroconvulsive therapy" (ECT). It examined placebo-controlled studies and concluded ECT had minimal benefits for people with depression and schizophrenia. [3] The authors said "given the strong evidence of persistent and, for some, permanent brain dysfunction, primarily evidenced in the form of retrograde and anterograde amnesia, and the evidence of a slight but significant increased risk of death, the cost-benefit analysis for ECT is so poor that its use cannot be scientifically justified". [4] Psychiatrists, however, sharply criticized this paper in passing by calling it an "evidence-poor paper with an anti-ECT agenda". [5]

Selected publications

See also

Related Research Articles

<span class="mw-page-title-main">Electroconvulsive therapy</span> Medical procedure in which electrical current is passed through the brain

Electroconvulsive therapy (ECT) is a psychiatric treatment where a generalized seizure is electrically induced to manage refractory mental disorders. Typically, 70 to 120 volts are applied externally to the patient's head, resulting in approximately 800 milliamperes of direct current passing between the electrodes, for a duration of 100 milliseconds to 6 seconds, either from temple to temple or from front to back of one side of the head. However, only about 1% of the electrical current crosses the bony skull into the brain because skull impedance is about 100 times higher than skin impedance.

<span class="mw-page-title-main">Fluphenazine</span> Chemical compound

Fluphenazine, sold under the brand name Prolixin among others, is a high-potency typical antipsychotic medication. It is used in the treatment of chronic psychoses such as schizophrenia, and appears to be about equal in effectiveness to low-potency antipsychotics like chlorpromazine. It is given by mouth, injection into a muscle, or just under the skin. There is also a long acting injectable version that may last for up to four weeks. Fluphenazine decanoate, the depot injection form of fluphenazine, should not be used by people with severe depression.

Richard Bentall is a Professor of Clinical Psychology at the University of Sheffield in the UK.

<span class="mw-page-title-main">Perphenazine</span> Antipsychotic medication

Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the United States as Trilafon, it has been in clinical use for decades.

<span class="mw-page-title-main">David Healy (psychiatrist)</span> Irish-born pharmacologist

David HealyFRCPsych, a professor of psychiatry at Bangor University in the United Kingdom, is a psychiatrist, psychopharmacologist, scientist and author. His main areas of research are the contribution of antidepressants to suicide, conflict of interest between pharmaceutical companies and academic medicine, and the history of pharmacology. Healy has written more than 150 peer-reviewed articles, 200 other articles, and 20 books, including The Antidepressant Era, The Creation of Psychopharmacology, The Psychopharmacologists Volumes 1–3, Let Them Eat Prozac and Mania: A Short History of Bipolar Disorder.

The Hearing Voices Movement (HVM) is the name used by organizations and individuals advocating the "hearing voices approach", an alternative way of understanding the experience of those people who "hear voices". In the medical professional literature, ‘voices’ are most often referred to as auditory verbal hallucinations. The movement uses the term ‘hearing voices’, which it feels is a more accurate and 'user-friendly' term.

Hearing Voices Networks, closely related to the Hearing Voices Movement, are peer-focused national organizations for people who hear voices and supporting family members, activists and mental health practitioners. Members may or may not have a psychiatric diagnosis. Networks promote an alternative approach, where voices are not necessarily seen as signs of mental illness and regard hearing voices as a meaningful and understandable, although unusual, human variation. Voices are not seen as the problem, rather it is the relationship the person has with their voices that is regarded as the main issue.

Biological psychiatry or biopsychiatry is an approach to psychiatry that aims to understand mental disorder in terms of the biological function of the nervous system. It is interdisciplinary in its approach and draws on sciences such as neuroscience, psychopharmacology, biochemistry, genetics, epigenetics and physiology to investigate the biological bases of behavior and psychopathology. Biopsychiatry is the branch of medicine which deals with the study of the biological function of the nervous system in mental disorders.

<span class="mw-page-title-main">Jim van Os</span>

Jim van Os is a Dutch academic and psychiatrist. He is Professor of Psychiatry and medical manager of the Brain Center at Utrecht University Medical Center, the Netherlands.

<span class="mw-page-title-main">Psychotic depression</span> Medical condition

Psychotic depression, also known as depressive psychosis, is a major depressive episode that is accompanied by psychotic symptoms. It can occur in the context of bipolar disorder or major depressive disorder. It can be difficult to distinguish from schizoaffective disorder, a diagnosis that requires the presence of psychotic symptoms for at least two weeks without any mood symptoms present. Unipolar psychotic depression requires that psychotic symptoms occur during severe depressive episodes, although residual psychotic symptoms may also be present in between episodes. Diagnosis using the DSM-5 involves meeting the criteria for a major depressive episode, along with the criteria for "mood-congruent or mood-incongruent psychotic features" specifier.

<span class="mw-page-title-main">Waxy flexibility</span> Catatonia psychomotor symptom

Waxy flexibility is one of the twelve symptoms that can lead to the diagnosis of catatonia. It is a psychomotor symptom that results in a decreased response to stimuli and a tendency to remain in an immobile posture. If one were to move the arm of someone with waxy flexibility, the patient would keep that arm where it had been positioned until moved again as if positioning malleable wax. Attempts to reposition the patient are met by "slight, even resistance".

Early intervention in psychosis is a clinical approach to those experiencing symptoms of psychosis for the first time. It forms part of a new prevention paradigm for psychiatry and is leading to reform of mental health services, especially in the United Kingdom and Australia.

Nidotherapy, after nidus, is an experimental form of psychotherapy, described as "a collaborative treatment involving the systematic assessment and modification of the environment to minimize the impact of any form of mental disorder on the individual or on society".

A persecutory delusion or persecution complex is a common type of delusional condition in which the affected person believes that harm is going to occur to oneself by a persecutor, despite a clear lack of evidence. The person may believe that they are being targeted by an individual or a group of people. Persecution delusions are very diverse in terms of content and vary from the possible, albeit improbable, to the completely bizarre. The delusion can be found in a multitude of disorders, being more usual in psychotic disorders, such as schizophrenia, schizoaffective disorder and delusional disorder.

The word schizophrenia was coined by the Swiss psychiatrist Eugen Bleuler in 1908, and was intended to describe the separation of function between personality, thinking, memory, and perception. He introduced the term on 24 April 1908 in a lecture given at a psychiatric conference in Berlin and in a publication that same year. Bleuler later expanded his new disease concept into a monograph in 1911, which was finally translated into English in 1950.

<span class="mw-page-title-main">Patrick McGorry</span> Australian psychiatrist

Patrick Dennistoun McGorry FAA FASSA FAHMS FRCP FRANZCP is an Irish-born Australian psychiatrist known for his development of the early intervention services for emerging mental disorders in young people.

<span class="mw-page-title-main">Kraepelinian dichotomy</span>

The Kraepelinian dichotomy is the division of the major endogenous psychoses into the disease concepts of dementia praecox, which was reformulated as schizophrenia by Eugen Bleuler by 1908, and manic-depressive psychosis, which has now been reconceived as bipolar disorder. This division was formally introduced in the sixth edition of Emil Kraepelin's psychiatric textbook Psychiatrie. Ein Lehrbuch für Studirende und Aerzte, published in 1899. It has been highly influential on modern psychiatric classification systems, the DSM and ICD, and is reflected in the taxonomic separation of schizophrenia from affective psychosis. However, there is also a diagnosis of schizoaffective disorder to cover cases that seem to show symptoms of both.

<i>Doctoring the Mind</i>

Doctoring the Mind: Why psychiatric treatments fail is a 2009 book by Richard Bentall, his thesis is critical of contemporary Western psychiatry. Bentall, a professor of clinical psychology, argues that recent scientific research shows that the medical approach to mental illness is fatally flawed. According to Bentall, it seems there is no "evidence that psychiatry has made a positive impact on human welfare" and "patients are doing no better today than they did a hundred years ago".

Psychiatry is, and has historically been, viewed as controversial by those under its care, as well as sociologists and psychiatrists themselves. There are a variety of reasons cited for this controversy, including the subjectivity of diagnosis, the use of diagnosis and treatment for social and political control including detaining citizens and treating them without consent, the side effects of treatments such as electroconvulsive therapy, antipsychotics and historical procedures like the lobotomy and other forms of psychosurgery or insulin shock therapy, and the history of racism within the profession in the United States.

Benedicto Crespo Facorro is a psychiatrist and professor of psychiatry with the School of Medicine at the Hospital Universitario Virgen del Rocío, Universidad de Sevilla, in Seville. Facorro is notable for his research work in the area of early psychosis and schizophrenia and for having led one of the first early psychosis early intervention programs in Spain (PAFIP) for over two decades. Facorro is one of the only four researchers from Spain listed in the authors' collaborative network of the authors that published the greatest number of research papers on antipsychotics and schizophrenia over the last 50 years.

References

  1. 1 2 Department of Psychology, University of Auckland. "John Read Biography". Archived from the original on 29 February 2012.
  2. "Prestigious Awards in Psychology". NZDoctor. 26 July 2010. Archived from the original on 22 September 2013. Retrieved 16 March 2012.
  3. Richard Baker and Nick McKenzie (6 September 2011). "Mental health care inquiry". The Age.
  4. Read, J; Bentall, R (October–December 2010). "The effectiveness of electroconvulsive therapy: a literature review" (PDF). Epidemiologia e Psichiatria Sociale. 19 (4): 333–47. doi:10.1017/S1121189X00000671. PMID   21322506. Archived from the original (PDF) on 24 May 2012. Retrieved 17 March 2012.
  5. McCall WV, Andrade C, Sienaert P (2014). "Searching for the mechanism(s) of ECT's therapeutic effect". The Journal of ECT. 30 (2): 87–9. doi:10.1097/YCT.0000000000000121. PMC   4695970 . PMID   24755719.
  6. Read, J; Bentall, R (2010). "The effectiveness of electroconvulsive therapy: a literature review". Epidemiol Psychiatr Sci. 19 (4): 333–47. doi:10.1017/S1121189X00000671. PMID   21322506.